chrisvoncsefalvay/vaers-outcomes huggingface dataset:
still has is twitching in the muscle in his right arm, which is the arm he got the shot in; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 50 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm right, administration date 02May2021 11:00 (Lot number: ER8735) at the age of 50 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose (Arm Right), Lot number: ER8732), administration date: 02Apr2021, for Covid-19 Immunization, reaction(s): "Headache", "muscle aches and pains", "muscle aches and pains", "diarrhea", "fever", "fatigue/tired", "right arm twitching", "tested positive for Covid". The following information was reported: MUSCLE TWITCHING (non-serious) with onset May2021, outcome "not recovered", described as "still has is twitching in the muscle in his right arm, which is the arm he got the shot in". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: No additional vaccine was administered on same date of the Pfizer suspect. The event did not result in emergency room or physician office. No Prior Vaccinations administered within 4 weeks. No family medical history.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021518944 same patient, similar event; different dose
Lg cm of erythema and induration to posterior (L) VE-approx 10 cm in diameter tx with Medrol dose pack
Client reported extreme muscle pain and paralysis, she was unable to lift her arm. Reports that she still has muscle pain.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and gender. Concurrent conditions and medical history were not reported. On 21-JUL-2015, the nurse provided details on to vaccine stability revaluated for (Oka/Merck) VARIVAX and reported that on 21-JUL-2015, the patients were vaccinated with an improperly stored doses of (Oka/Merck) VARIVAX (lot number, expiration date, dose and route were not reported). Concomitant medications were not reported. No adverse symptoms were reported. Additional information has been requested.
Patient noticed stinging during injection. Stinging progressed to pain and around 5 PM he noticed redness, swelling, fever. Left deltoid. As of today, swelling, etc...had spread down to (L) elbow area.
About 4 and 1/2 hours after immunization, patient experienced redness, swelling and pain at injection site. The area of redness enlarged over the next few days. She used cold compress and began taking Benadryl on the day following the immunization. By 9/25/17, 4 days after injection, the redness and swelling continued and there was a nodule at injection site. She went to her primary care nurse practitioner that day for examination and was give Prednisone 10mg daily for 3 days and Cephalexin 500mg twice daily for 7 days. She began taking meds that same day.
Patient was in usual good state of health until 12/2003. He noted a significant change in his health after receiving anthrax vaccine #4, in 11/2003 and his flu vaccine in 12/2003 when he began feeling weak. In late 12/2003 early 01/2004, he also noted muscle and joint pain that first started with his hands, thumbs and wrist, then his elbows and shoulders. Another change in his health that was noted in 12/2003 is chronic fatigue. Since returning stateside in 06/2004, patient has noted night sweats and a decreased tolerance to cold. He often wakes up with his nightclothes and bed linens damp with perspiration. Comment: patient received anthrax vaccines 1-3 during Feb- April 2003 and denies any significant or prolonged local or systemic reactions. Patient does not recall any significant local reaction or any worsening of his systemic symptoms with vaccines subsequent to 12/2003, including anthrax vaccine #5 received in April 2004.
pt recv vax & devel a severe localized rxn which resolved on it's own;no further detail available as of the date of this report;
passed out; had quite a reaction to the booster; nauseous; vomited; had a very intense headache; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (passed out), VACCINATION COMPLICATION (had quite a reaction to the booster), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027H21B, 011A21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In November 2021, the patient experienced LOSS OF CONSCIOUSNESS (passed out), VACCINATION COMPLICATION (had quite a reaction to the booster), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache). At the time of the report, LOSS OF CONSCIOUSNESS (passed out), VACCINATION COMPLICATION (had quite a reaction to the booster), NAUSEA (nauseous), VOMITING (vomited) and HEADACHE (had a very intense headache) outcome was unknown.            She says that she had quite a reaction to the booster. Patient stated that about 15 hours after the 2nd dose & booster dose patient was nauseous, vomited, passed out, & had a very intense headache.  Concomitant products were not provided.  Treatment medication were not reported.   This case was linked to MOD-2021-406073 (Patient Link).
FEVER, CHILLS, BODY ACHES, DIARRHEA, NAUSEA LASTING FOR 4 DAY. FEELING BETTER ON DECEMBER 23RD 2022
Within 2 hours of receiving BEXSERO pt developed nausea, dizziness, chills temps 100.6. Pt vomited 4x.
Pt felt "feverish," and felt "swelling in his throat." Friend phoned 911, and pt was transported to ER. Pt states he was given epinephrine, Benadryl, and a steroid injection. Was diagnosed by ER physician with an allergic reaction to the menigitis vaccine. Was monitored in ER and discharged on prednisone PO.
Approximately 1-2 minutes after receiving GARDASIL-9 HPV vaccine and seasonal influenza vaccine, patient felt hot and then cold/shivering, elevated heart rate, temp. 100.2 Fahrenheit, elevated blood pressure, flushed face, slight puffiness in cheeks. This lasted approx. 2 hours.
Body ache, fever, chills, headache, body sore. Couldn't move fast
Child was given 2 Tdap vaccines on same date.  1st  in Right deltoid and 2nd in Left deltoid. Per father on 5/6/19- child was fine, and had no untoward reactions.
I came back from vacation and thought I had allergies. I was unable to smell the day after I got home. I tested a few days later. On day five is when I started having trouble with my breathing. I spent about a week in bed and had a ton of SOB. I was weak and my body was aching. I also had my heart rate go up and it was constantly racing. This led me to get testing because this heart racing continued beyond my other symptoms resolved.
She had a Pfizer Covid vaccine 3 March 2021, and her second dose 15 June 2021 and a booster 27 September 2021 She had gastric sleeve with cholecystectomy 23 March 2021 1 week later she started having significant diarrhea and abdominal pain which ultimately prompted a  CT abdomen pelvis 13 April 2021 showing extensive near occlusive portal vein thrombosis with SMV thrombosis, she began Lovenox CT abdomen pelvis 23 April 2021 showed no significant change to subtle decrease in extensive portal vein thrombosis CT angio 10 June 2021 showed stable portal vein thrombosis CT abdomen pelvis 8 July 2021 showed no significant change in portal vein thrombosis, no lymphadenopathy, trace ascites, mild colonic thickening/stranding CT abdomen pelvis 20 September 2021 showed partially occlusive thrombus through portal vein system, no significant change, with secondary colonic thickening and stranding likely secondary to thrombosis  During this process, due to ongoing diarrhea 14-16 times per day she was started on TPN but since TPN has been discontinued and she is back on a healthy diet, also aspirin 81 mg daily had been added, DOAC is being avoided due to history of bariatric surgery, no family history of thrombosis
Pt required COVID 19 testing prior to surgery and tested positive 6/6/21.  Pt was asymptomatic for COVID.  His surgery had to be delayed.
1 week after the shot, I felt pain and itching at the site.  It was hard and swollen with redness around it.  Improved some with an antihistamine.   On the next day, it was more red and painful.   The day before I was working in the yard and thought I may have got it infected.  I did call my health care physician, and was prescribed clindamycin. It got better then worse so I did seek care on the 5th day but did not take the recommended prednisone and then improved much after 6 days.
Dizziness and light headedness beginning approximately four (4) hours after injection. Currently (04/10/2021) experiencing  mild light headedness and impaired ability to mentally concentrate and focus.  Mild pain with palpation at injection site.
No adverse effects.  Administration error. Pt. was given a pediatric dose instead of adult dose. An adult dose was administered later that day.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 06-MAR-2012 and 28-MAR-2013, the patient was respectively vaccinated with the first dose and the second dose of GARDASIL, (lot#, dose and strength not reported). Patient is not currently in the office for dose three. No adverse effects reported. It was unspecified if the patient sought medical attention. Additional information has been requested.
Genetalia has been sore and somewhat painfully itchy ever since the first shot. It has been three months and this has not subsided. I have been tested for all STDs and all tests came back negative. No visible bumps or irregularities besides for pink skin on scrotum.
Slight fever; Feeling tired; This is a spontaneous report from a contactable consumer or other non HCP (wife). A male patient of an unspecified age received bnt162b2 (BNT162B2, formulation; Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot Number: Not Provided) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included first dose of bnt162b2 on unspecified date for covid-19 immunisation. The patient experienced slight fever and feeling tired on an unspecified date. The outcome of events was unknown.  The lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
end up with vasculitis after receiving the Moderna vaccines; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VASCULITIS (end up with vasculitis after receiving the Moderna vaccines) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Patient never had COVID positive test or diagnosis and did not take other vaccines within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Drug allergy (Patient was allergic to certain Opioid Percocet.) and Vasculitis.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VASCULITIS (end up with vasculitis after receiving the Moderna vaccines). At the time of the report, VASCULITIS (end up with vasculitis after receiving the Moderna vaccines) outcome was unknown.            Patient height was reported as 5.4 F.  Patient was taking other unspecified medication.  Patient had the primary doses and the first booster.  Treatment information was not provided by the reporter.
Patient said that it feels hot at the left side of her neck. She noted that after the injection she felt fatigued and had to head home and lay down. Told her that usually feel fatigue after the vaccine.  She described whenever she yawns she cannot control it. Currently has a fever the next morning 100.4F.  Told her to have primary care provider to look at it.
7 days after shot developed intense itching in left palm, minimally relieved w steroid cream.itching spread to wrist and back of hand. Both areas  were slightly edematous pitting at the wrist. NO breathing No wheezing or SOB. Minimal help from Benadryl. About 0230 I took 2 naproxen, which helped a lot. As of this am pain redness swelling markedly improved.
Patient not feeling well after receiving Moderna COVID-19 booster; This spontaneous case was reported by a consumer and describes the occurrence of IMMUNISATION REACTION (Patient not feeling well after receiving Moderna COVID-19 booster) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Psoriasis.    The patient's past medical history included Muscle pain in 2020.   In January 2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) 150 milligram. In January 2022, the patient experienced IMMUNISATION REACTION (Patient not feeling well after receiving Moderna COVID-19 booster). At the time of the report, IMMUNISATION REACTION (Patient not feeling well after receiving Moderna COVID-19 booster) had not resolved.            No concomitant medication provided. No treatment information mentioned.  In Jan of 2021, patient was not feeling well after taking the Moderna COVID booster.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in
None Stated Received autopsy report which revealed COD as undetermined.  Patient was cosleeping w/adult.
Headache, sweating, warmth and pallor immediately after immunizations followed by syncope.
DIFFICULTY SPEAKING; SEVERE MIGRAINE IN HER FRONTAL LOBE (FRONT OF HER HEAD); SWELLING AT ONE SIDE OF THE FACE; SORE ARM; MINOR FEVER; URTICARIA FLARE-UP; This spontaneous report received from a consumer concerned a 39 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included idiopathic chronic urticaria, alcohol user, and non-smoker. The patient experienced vaccine allergy when treated with influenza vaccine inact split 4v. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A expiry: 21-JUN-2021) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced swelling at one side of the face. On 06-APR-2021, the subject experienced sore arm. On 06-APR-2021, the subject experienced minor fever. On 06-APR-2021, the subject experienced urticaria flare-up. On 20-APR-2021, the subject experienced severe migraine in her frontal lobe (front of her head). On 20-APR-2021, the subject experienced difficulty speaking. Treatment medications (dates unspecified) included: prednisone, and paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from swelling at one side of the face, sore arm, and minor fever on APR-2021, had not recovered from severe migraine in her frontal lobe (front of her head), and the outcome of urticaria flare-up and difficulty speaking was not reported. This report was non-serious.
5 weeks post injection #1 patient presents with a pulmonary embolism.  Second dose was not received at 3 weeks.
Patient sat in waiting area after administration of Moderna Vaccine. Patient fell to the floor about 7-8 minutes later. I ran to her she was conscious. She was mumbling a bit said she felt hot.  I took her temperature was at 98.1 F. Patient said she felt weird she also thought it was her anxiety. She wanted to make sure her son was ok he was sitting next to her.She was able to slowly get up and sat on chair. We fanned her down as she was sweating and was pale. She drank some water. Paramedics were called they asked her if she wanted to go to the hospital she said she was ok. Her uncle arrived and took her home.
Temp to 101.4 F, myalgia, fatigue, local pain, DIARRHEA with frequent liquid stools beginning with a few episodes 6 hours post injection, but then progressing to q60-90 minutesfor the next 24 hours.
Massive headache; took Advil but the headache still persists.  Will be trying Excedrin Migraine today. Site area very tender to the touch.
Rt arm bruising, moderate edema from inj. site to wrist. Nontender no joint pain.
started: 2-16-21 after leaving had redness did not want to disclose information other than the reaction she had. informed her without knowing allergies, her medical conditions, or medication she's taking (that may interact with recommendation therapy) I would feel uncomfortable recommending medication. recommended she see her pcp for treatment. verbalized understanding.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 63-year-old male patient received BNT162b2 (BNT162B2), on 26Jan2021 as dose 1, single (Lot number: EL3249), in right arm, on 17Feb2021 at 14:00 as dose 2, single (Lot number: WL9269), in right arm and on 24Sep2021 at 14:00 as dose 3 (booster), single (Lot number: 301308A) at the age of 63 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Heart disease" (unspecified if ongoing); "diabetes" (unspecified if ongoing). Concomitant medication(s) included: LIPITOR, start date: 01Feb2021, stop date: 02May2022; PLAVIX, start date: 01Feb2022; PROTONIX [OMEPRAZOLE], start date: 01Feb2021; METOPROLOL, start date: 01Feb2021; METFORMIN, start date: 01Feb2021; JARDIANCE, start date: 01Feb2021, also these were medications taken in 2 weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID -19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06May2022) Negative; (12May2022) Positive; (30Apr2022) Positive, notes: Symptoms much worse than initial positive test from April 30th. Therapeutic measures were taken as a result of sars-cov-2 test positive included Paxlovid, treatment start date: 02may2022, treatment stop date: 06may2022.  Clinical course: Covid relapse occurred about 4 days after treatment with Paxlovid ended. Treatment start on 02May and ended on 06May. Tested negative with rapid antigen test on 06May. Started feeling bad on 10May with a positive Covid antigen test on 12May. Symptoms much worse than initial positive test from 30April.  Follow-up attempts completed. No further information is expected.
Experiencing rancid smells with food that make eating difficult.; Experiencing rancid smells with food that make eating difficult.; This is a spontaneous report from a non-contactable consumer (patient) or other non hcp. A 26-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9261 and expiry date: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 27Jan2021 at 15:30 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included covid-19. The patient had no known allergies. Concomitant medication included ethinylestradiol, norethisterone (PIRMELLA). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient experienced experiencing rancid smells with food that make eating difficult on 02Feb2021. No treatment was received for the event. Outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Chest pain, shortness of breath, Headache, gastrointestinal distress, malaise. One week after the injection I am still having continuous chest pain/discomfort and shortness of breath, tired.
I26.99 PULMONARY EMBOLISM, UNSPECIFIED. 12/31/2021 HYPOTHYROIDISM
about 10 minutes after vaccination, pt began itching and hives. continued to develop into rash from "top of head to below my waist". called primary care doctor for relief.Treated with oral diphenhydramine and prednisone for about 3 days, with itching returning throughout the days as the doses wore off. At day 4, patient reports the symptoms were no longer bothersome.
Patient reported that she became very dizzy and actually fell down, she felt flu-like and her legs had no strength.
1) shortly after: major headache, nausea, extremely tired, continued throughout the day. Took 2 aspirin 2) Friday, May 10: point of entry mottled pink, warm and swollen, headache, nausea, very tired, itchiness on stomach - no visible rash, continued throughout day. Took 2 aspirin 3) Saturday, May 11: point of entry mottled pink, hot and swollen, warm nausea, mild rash on stomach, barely visible, but slightly itchy. Ate lunch at a restaurant, may have included some of my food intolerances 4) Sunday, May 12: point of entry no discoloration, warm and swollen, nausea, rash on stomach, tired but insomnia that night. Rested/read all day. 5) Monday, May 13: point of entry nausea warm but not swollen, rash more evident on stomach and more itchiness. Used some essential oils, called Dr.'s office. They suggested benadryl.  I had shingles before and this feels the same to me: I am uncomfortable but not in pain and I can ignore the itchiness. Plus I used essential oils at that time, which worked for me. Currently using Ancient Wisdom Painless, a blend of Birch (Betula alleghaniensis), helichrysum (Helichrysum italicum), clove (Syzygium aromaticum) and peppermint (Mentha piperita). I will be adding different blends, when I find the recipe for what I used previously.
Patient was nervous about receiving vaccine. After administration, he stood up and let his dad sit down to get his vaccine and while I was finishing with his dad, the patient fainted. I gave him crackers and juice and had him sit until his symptoms of dizziness were completely gone.